Page 6 - Martin Gouldstone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Oxford, U.K. 5 February 2021 : Sensyne Health plc (LSE: SENS) ( Sensyne or the Company or the Group ), the UK Clinical AI company, announces that it has appointed Hina Zaman as Managing Director of its Healthcare Division and Martin Gouldstone as Chief Business Officer of its Life Sciences Division. Hina Zaman joins Sensyne from Babylon Health, where as Product Director she led the company s global product for value-based care and previously its global product proposition in the women s health space. Prior to that, Hina founded the UK s first virtual care platform for women s health, pioneering a new model of personalised, proactive care for health consumers. Hina has extensive experience as a healthcare management consultant, leading change initiatives across the NHS commissioning and provider landscape while at Finnamore Ltd. (now part of GE Healthcare), and in US healthcare systems while at Deloitte

United kingdomCity ofMichael norrisRichard pyeMartin gouldstoneMary jane elliottSukaina virjiFreng fmedsciHealthcare divisionLife sciences divisionCapital solutions at syneosMarket of the london stock exchangeBabylon healthSensyne healthFinnamore ltdHead of life sciences